- Home
- ANET vs MRK Comparison
ANET vs MRK Comparison
Compare ANET & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANET
- MRK
- Stock Information
- Founded
- ANET 2004
- MRK 2000
- Country
- ANET United States
- MRK United States
- Employees
- ANET N/A
- MRK N/A
- Industry
- ANET Computer Communications Equipment
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- ANET Telecommunications
- MRK Health Care
- Exchange
- ANET Nasdaq
- MRK Nasdaq
- Market Cap
- ANET 176.0B
- MRK 198.5B
- IPO Year
- ANET 2014
- MRK N/A
- Fundamental
- Price
- ANET $153.03
- MRK $85.16
- Analyst Decision
- ANET Strong Buy
- MRK Buy
- Analyst Count
- ANET 14
- MRK 14
- Target Price
- ANET $141.31
- MRK $108.54
- AVG Volume (30 Days)
- ANET 8.2M
- MRK 11.6M
- Earning Date
- ANET 11-06-2025
- MRK 10-30-2025
- Dividend Yield
- ANET N/A
- MRK 3.81%
- EPS Growth
- ANET 31.78
- MRK 20.41
- EPS
- ANET 2.55
- MRK 6.49
- Revenue
- ANET $7,950,946,000.00
- MRK $63,616,000,000.00
- Revenue This Year
- ANET $27.23
- MRK $1.91
- Revenue Next Year
- ANET $18.48
- MRK $4.97
- P/E Ratio
- ANET $60.03
- MRK $13.13
- Revenue Growth
- ANET 25.97
- MRK 1.82
- 52 Week Low
- ANET $59.43
- MRK $73.31
- 52 Week High
- ANET $156.32
- MRK $119.38
- Technical
- Relative Strength Index (RSI)
- ANET 76.41
- MRK 55.95
- Support Level
- ANET $139.51
- MRK $83.54
- Resistance Level
- ANET $145.46
- MRK $84.80
- Average True Range (ATR)
- ANET 4.41
- MRK 1.41
- MACD
- ANET 0.79
- MRK -0.11
- Stochastic Oscillator
- ANET 87.78
- MRK 48.36
About ANET Arista Networks Inc.
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.